ADAG
Adagene · USD
Deep AI analysis (big model)
No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.
About Adagene
Adagene (ADAG) is a biotechnology company focused on developing and commercializing novel therapies for cancer treatment by targeting the tumor microenvironment.
| Ticker | ADAG |
| Name | Adagene |
| Currency | USD |
| Sector | Healthcare |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.
Candlestick, volume & news sentiment
Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).
Technical analysis
NEUTRALComputed from 258 locally-stored price bars.
AI signals
-
HOLD 70% · long_term 2026-06-08 10:11
The stock has been in a downtrend with no significant positive news or catalysts to reverse this trend. The recent close at 3.32 is near the lowest point observed over the last week, indicating continued weakness and lack of support from buyers.
qwen2.5:3b
Related news
- No matched headlines yet.